If you miss more than 2 weeks in a row: Take your next dose on the regularly scheduled day or call your healthcare provider to talk about how to restart your treatment
The combination is biochemically logical, but there is not yet a strong human trial proving that NMN + TMG yields better longevity outcomes than NMN alone
It is important to remember that peptide dosing should always be approached cautiously, and medical guidance is recommended
The SELECT trial showed that semaglutide reduced major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in adults with obesity and established cardiovascular disease, without requiring a diabetes diagnosis. The FLOW trial showed kidney benefits with semaglutide use in patients with type 2 diabetes and chronic kidney disease. Improvements in hard clinical outcomes like cardiac events, kidney disease, and death are commonly observed with GLP-1 use, and are due to both the direct effects of treating the obesity, and indirect effects of the medications themselves
No noticeable tumor invasion was identified in the teeth
